v3.26.1
Share-based Compensation
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation

14. SHARE-BASED COMPENSATION

The following table presents share-based compensation expense included in the accompanying condensed consolidated statements of operations and comprehensive (loss) income:

 

 

 

Three Months Ended March 31,

 

(In thousands)

 

2026

 

 

2025

 

Cost of goods manufactured and sold

 

$

1,753

 

 

$

1,782

 

Research and development

 

 

8,468

 

 

 

5,891

 

Selling, general and administrative

 

 

26,109

 

 

 

15,137

 

Share-based compensation expense

 

 

36,330

 

 

 

22,810

 

Research and development

 

 

5,940

 

 

 

 

Selling, general and administrative

 

 

12,468

 

 

 

 

Share-based compensation expense for acceleration of Avadel Shares

 

 

18,408

 

 

 

 

Total share-based compensation expense

 

$

54,738

 

 

$

22,810

 

At March 31, 2026 and December 31, 2025, $3.3 million and $3.2 million, respectively, of share-based compensation expense was capitalized and recorded as “Inventory”, and $2.1 million and $1.6 million, respectively, of share-based compensation expense was capitalized and recorded as “Other assets” in the accompanying condensed consolidated balance sheets.

During the three months ended March 31, 2026, share-based compensation expense included: (i) $18.4 million in post-combination expense related to Avadel Shares that were accelerated and settled by the Company on the Closing Date in connection with the Avadel Acquisition; (ii) $1.8 million in post-combination expense related to the contingent liability related to the potential CVR payment to former Avadel employees and (iii) $4.9 million in expense related to certain equity awards that were modified by the letter agreement entered into in February 2026 between the Company and Richard Pops (the “Letter Agreement”) in connection with Mr. Pops’ upcoming retirement from his position as the Company’s Chief Executive Officer. The share-based compensation expense related to these events consisted of $18.5 million in selling, general and administrative expense and $6.6 million in R&D expense.

The Company expects to record an additional $1.1 million in incremental share-based compensation expense through May 2027 in connection with the equity modification resulting from the Letter Agreement.